Drug Information

Drug General Information
Drug ID
D02FCU
Former ID
DCL001214
Drug Name
MIV-210
Drug Type
Small molecular drug
Indication HBV infection [ICD9: 070.2-070.3; ICD10:B16, B18.0, B18.1] Phase 2 [551136]
Company
Medivir; Daewoong
Structure
Download
2D MOL

3D MOL
Formula
C10H12FN5O3
Canonical SMILES
C1C(C(OC1N2C=NC3=C2NC(=NC3=O)N)CO)F
InChI
1S/C10H12FN5O3/c11-4-1-6(19-5(4)2-17)16-3-13-7-8(16)14-10(12)15-9(7)18/h3-6,17H,1-2H2,(H3,12,14,15,18)/t4-,5+,6+/m0/s1
InChIKey
RTJUXLYUUDBAJN-KVQBGUIXSA-N
PubChem Compound ID
72183
PubChem Substance ID
595910, 16339424, 43128393, 50163390, 57318575, 103109344, 104352309, 117602033, 121184800, 129179054, 131331715, 134224064, 135030726, 139819825, 163204944, 171579249, 184538642, 198940158, 223830409, 227179200, 240472629, 252329442, 252475680, 252671959
Target and Pathway
Target(s) DNA polymerase/reverse transcriptase Target Info Modulator
References
Ref 551136Clinical pipeline report, company report or official report of Medivir (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.